San Juan Capistrano, Calif. – Beginning today, Quest Diagnostics will begin testing for the monkeypox virus. The company has developed a real-time polymerase chain reaction or PCR test that can detect non-variola orthpoxviruses and monkeypox virus,  from a swab specimen of a patient.  The test is available to healthcare providers nationwide with the exception of New York where it will be available at a later date. . Quest Diagnostics plans to make the test available to healthcare providers in the first half of August and will offer monkeypox virus testing at the company’s advanced laboratory in San Juan Capistrano, Calif. where specimens from anywhere in the country can be collected for testing. Quest’s testing will continue to increase the current capacity provided through CDC’s Laboratory Response Network (LRN)Labcorp, and Mayo Clinic Laboratories, by providing testing capacity of up to 60,000 specimens a week by the end of July.

Anyone with a rash should talk to a healthcare provider about whether testing is necessary. Healthcare providers can order monkeypox virus testing from Quest as they normally would order other tests. People seeking testing for monkeypox must consult with their healthcare provider first as they cannot separately go to a Quest lab and submit a specimen, and request testing. Quest will use electronic laboratory reporting to report results to jurisdictions as outlined in the CDC reporting guidance.

CDC anticipates additional commercial laboratories will come online in the coming days, and monkeypox testing capacity will continue to increase throughout the rest of this month and into August.  Healthcare providers can access information on Quest’s test at**. The latest  information on the Monkeypox Virus  is available at